# Research, Innovation, Life, Leadership & Operations Foundation

**Foundation ID:** `HRIL-AIOS-LIFE-LEADERSHIP-1.0`  
**Install state:** Foundation staged; no power, connector, agent or external action enabled.

DISCOVER supports the leader as a scientist, innovator, portfolio steward, people leader and whole person. It separates organizational authority from personal aspiration, makes uncertainty visible, and ends every consequential path at a named accountable human. It is a planning and orchestration aid—not an IRB/HRO, EHR, CTMS, EDC, eConsent, safety-reporting, regulatory, grant, finance, procurement, patent or legal decision system.

## 9. Life, career, leadership and purpose foundation

The foundation should empower the person as well as the portfolio while preventing institutional capture of private life data.

### Organizational leadership components

- active-hat and authority map;
- research/innovation leadership mission and impact thesis;
- leadership values, non-goals and ethical red lines;
- capability map across science, implementation, innovation, finance, governance, partnerships and people leadership;
- scholarship and credibility plan without invented credentials;
- mentoring, sponsorship and peer-learning plan without contact scraping;
- team capability, delegation and succession questions without employee scoring;
- 90-day portfolio focus and decision calendar;
- protected development time and boundary negotiation prompts;
- legacy, knowledge-transfer and responsible closeout plan.

### Private owner-only components

- personal mission and desired contribution;
- career aspirations and possible future seasons;
- family, relationship, business and community commitments;
- protected time, energy budget and recovery commitments;
- overload signals defined by the owner and a **Minimum Viable Leadership Mode**;
- learning, creativity, play and nonwork identity;
- private red lines, sharing choices, review date and delete date;
- owner-selected bridge statements such as “unavailable after 6 p.m.” without disclosing the private reason.

The private store is optional. It must be cryptographically and logically isolated, owner-only, excluded from tenant analytics, training, exports and parent Mission Control, and deletable independently. No institutional role may require it or infer performance from its use/nonuse.

### Minimum Viable Leadership Mode

When the owner chooses minimum mode, Mission Control reduces the organizational view to:

1. one safety/governance blocker;
2. one time-sensitive human decision;
3. one delegated or deferred item;
4. one protected-life boundary; and
5. pause/kill/escalation controls.

The OS must not diagnose burnout, substitute for clinical or crisis support, or shame the user for reduced capacity.

---

## Human standard and truth discipline

Every output names owner, active hat, authority source/expiry, exact data class, sources, known/assumed/unknown facts, decision requested, qualified human gate, next review and discard/rollback path. Narrative outputs use plain, specific human language and remove filler, false certainty, invented empathy, fake quotations, generic praise and untraceable claims. **A polished draft is never an official record.**

## Authoritative source seed registry

These are **seeds to verify current**, not applicability determinations, legal advice, compliance findings, approval, or permission to act. The applicable source depends on jurisdiction, activity, sponsor/award, product, population, data, setting, date, local policy and contract. A named qualified local owner must confirm current version, scope, effective/compliance dates, local precedence and expiry before consequential use. The eCFR is authoritative but unofficial as an edition of the CFR; agency convenience pages and reproductions may also be unofficial. Always reconcile the official source and local counsel/office.

| Official seed | Exact HTTPS URL | Visible status at review | Pack implication | Local owner | Refresh |
|---|---|---|---|---|---|
| OHRP Decision Charts | https://www.hhs.gov/ohrp/regulations-and-policy/decision-charts/index.html | Official decision aid; 2018 Requirements charts dated 2020 | FRAME questions only; never an institutional determination | HRPP/IRB | Quarterly |
| 45 C.F.R. Part 46 | https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-46 | Binding/current in scope; verify current text | Human-subject protection reference | HRPP/IRB/legal | On every use |
| OHRP QI FAQ | https://www.hhs.gov/ohrp/regulations-and-policy/guidance/faq/quality-improvement-activities/index.html | Official nonbinding FAQ | Do not infer research/QI status | HRPP/IRB/QI | Quarterly |
| HHS OCR HIPAA Research | https://www.hhs.gov/hipaa/for-professionals/special-topics/research/index.html | Official page; reviewed 2024-08-21 | Privacy questions and formal routes | Privacy Board/privacy/legal | Quarterly |
| HIPAA Security Rule NPRM | https://www.hhs.gov/hipaa/for-professionals/security/hipaa-security-rule-nprm/index.html | Proposed; existing Security Rule remains in effect | Separate current controls from future readiness | Security/privacy/legal | Monthly until final |
| 42 C.F.R. Part 93 | https://www.ecfr.gov/current/title-42/chapter-I/subchapter-H/part-93 | 2026 transition depends on allegation-received date | Confidential route; AI never makes misconduct findings | RIO/legal/ORI liaison | On intake |
| March 2026 NIHGPS | https://grants.nih.gov/policy-and-compliance/nihgps | Award/budget-period specific | Pin edition, notice, NOFO and award terms | Research administration | On award change |
| NIH BESH NOT-OD-26-067 | https://grants.nih.gov/grants/guide/notice-files/NOT-OD-26-067.html | Applies by covered due/solicitation date from 2026-05-25 | Ask date/NOFO; other obligations may remain | Research administration/HRPP | On application |
| NIH Data Management and Sharing | https://grants.nih.gov/policy-and-compliance/policy-topics/sharing-policies/dms | Current canonical policy topic; award-specific | DMS planning and repository questions | Research administration/data steward | Quarterly |
| NIH AI in Applications NOT-OD-25-132 | https://grants.nih.gov/grants/guide/notice-files/NOT-OD-25-132.html | Policy for submissions on/after 2025-09-25 | Human originality/responsibility and provenance | PI/research administration | On application |
| NIH Public Access Policy | https://grants.nih.gov/policy-and-compliance/policy-topics/public-access/nih-public-access-policy-overview | Covered manuscripts accepted on/after 2025-07-01 | Track dates/rights; no automatic disclosure | Library/research administration/TTO | On acceptance |
| FDA E6(R3) GCP | https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e6r3-good-clinical-practice-gcp | Final guidance, September 2025 | Quality-by-design prompts; regulations still govern | Regulatory/sponsor/PI | Quarterly |
| FDA AI Regulatory Evidence | https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-use-artificial-intelligence-support-regulatory-decision-making-drug-and-biological | Draft January 2025; not for implementation | Draft-informed prompts only | Regulatory/FDA liaison | Monthly |
| FDA Diversity Action Plans | https://www.fda.gov/regulatory-information/search-fda-guidance-documents/diversity-action-plans-improve-enrollment-participants-underrepresented-populations-clinical-studies | Draft; verify status | Do not treat draft as binding | Regulatory/HRPP/community | Monthly |
| FDA Good Machine Learning Practice | https://www.fda.gov/medical-devices/software-medical-device-samd/good-machine-learning-practice-medical-device-development-guiding-principles | Official guiding principles; scope-specific | Lifecycle questions, not device authorization | Regulatory/quality | Quarterly |
| NIST AI RMF 1.0 | https://www.nist.gov/itl/ai-risk-management-framework | Voluntary; revision underway in 2026 | Versioned Govern/Map/Measure/Manage prompts | Responsible AI owner | Quarterly |
| NIST Generative AI Profile | https://www.nist.gov/publications/artificial-intelligence-risk-management-framework-generative-artificial-intelligence | Voluntary; page updated 2026-04-08 | Confabulation, injection, privacy and provenance tests | Responsible AI/security | Quarterly |
| HHS Section 504 Web/Mobile | https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-84/subpart-I/section-84.84 | Binding in scope; 2026 amendment and entity-specific 2027/2028 dates | Build/test to WCAG 2.1 AA; determine coverage | Accessibility/legal | Quarterly |
| DOJ Title II Web Rule | https://www.ada.gov/resources/2024-03-08-web-rule/ | Binding for covered public entities; extended dates | Entity/date-specific accessibility route | Accessibility/legal | Quarterly |
| Public Law 119-83 | https://www.govinfo.gov/content/pkg/PLAW-119publ83/html/PLAW-119publ83.htm | Enacted 2026-04-13; SBIR/STTR through 2031-09-30 | Security diligence questions; no eligibility certification | Research administration/security | On solicitation |
| USPTO AI-Assisted Inventorship | https://www.govinfo.gov/content/pkg/FR-2025-11-28/html/2025-21457.htm | Agency guidance, 2025-11-28 | Preserve human contribution; counsel decides | Technology transfer/patent counsel | On invention |

**Volatility watch (reviewed 2026-07-16):** the 2026 42 C.F.R. Part 93 transition, March 2026 NIHGPS, NOT-OD-26-067 BESH change, September 2025 FDA E6(R3), draft FDA AI and Diversity Action Plan documents, NIH AI/public-access rules, 2026 accessibility amendments and dates, P.L. 119-83, 2025 USPTO AI-inventorship guidance, NIST AI RMF revision work, and the proposed HIPAA Security NPRM all require explicit version/status checks. `unknown`, `draft`, `proposed`, `superseded`, `conflicted` and `not locally reviewed` remain visible blockers.

The working product name is DISCOVER. It is independent and **not endorsed, certified, licensed, accredited, cleared, approved, or affiliated** with any cited agency, institution, standards body, sponsor or vendor. Framework alignment is not certification.
